Delivery Order SPE2DB20D3103-SPE2DB25FM5F5

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DX15D1022|SPE2DX25FUYTF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,854.60 firm fixed-price delivery order is for the supply of 4,566,133,855 units of 10% potassium chloride in 15 ml cups, with a period of performance through October 18, 2024. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains a $999,999,999 Indefinite...
This federal contract award for $27,911.28 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The delivery order contract is for the supply of 4564755230 - Potassium Chloride 10% (20 mEq/15 mL) cups, with a period of performance through May 31, 2024. This award is not associated with any set-aside program. AmerisourceBergen is an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $4,712.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4566707146 - Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has a firm fixed price and an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.38 firm fixed price contract is for the delivery of 500 units of Potassium Chloride Extended Release 20 MEQ Tablets, a generic medication used to treat potassium deficiencies. The award is not associated with a specific set-aside program, indicating open competition. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,525.52 delivery order is for the supply of Potassium Chloride Injection, a critical medical product used to treat potassium deficiency. The contract is a firm-fixed-price delivery order with a completion date of May 12, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,104.43 firm fixed-price delivery order is for the supply of 4560970833 potassium chloride extended-release 8 milliequivalent (MEQ) tablets in 500-count bottles. The contract has a performance period ending on May 18, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DX15D1107|SPE2DX23FAUYS, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,147.58 firm fixed-price delivery order is for 4560815681 - POTASSIUM CL ER 20 MEQ TABLET 100S, with a completion date of May 4, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,543.30, is a Firm Fixed Price Delivery Order for the supply of Potassium Phosphate 45 mmol/15 ml 15 ml. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,121.04 firm fixed-price contract is for the delivery of 4,560,136,472 units of potassium citrate extended-release 10 MEQ tablets. The contract has a period of performance through March 6, 2023 and was awarded on March 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,178.99 firm fixed-price delivery order contract covers the supply of 4566832016 - Potassium Phosphate 45 mmol/15 ml, a pharmaceutical product, with a period of performance through January 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds an Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5F5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,192.10 firm fixed-price delivery order contract covers the supply of potassium chloride 10 MEQ/100 ML solution.

The contract is not designated as a set-aside award. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/1/25, 10:23 AM